84TiP - HER-Seq: A blood-based genomic screening study to identify HER2 mutation-positive patients for enrollment into clinical trials with the pan-HER inhibitor neratinib
| Autor: | Tomasevic, Z., Smyth, L.M., Saura, C., Boni, V., Garcia-Sáenz, J.Á., Prat, A., Eli, L., Garza, S.J., Lalani, A.S., Crown, J.P. |
|---|---|
| Zdroj: | In Annals of Oncology May 2019 30 Supplement 3:iii25-iii25 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|